everyone you, call. XXXX Thank on and first our good joining quarter us conference to listening. Thank for morning you Lee
install our I'm since installed has quarter Xst, four bringing base ALLY running say having more and that hit April the five XXXX, to in to LENSAR total XX. ground in the systems first proud
the over have XXXX. XX quarter -- the next and as in May install systems another also backlog of this XXth, quarter. We over These will next
the of with of Procedure US number in last small, growing ALLY in volumes nicely first when part users. the by year, but quarter increase the driven compared
reflect first availability, commercial we it's of launch on of that technology, has been deal months ophthalmic successful several targeted for community in controlled great As our the our a ALLY's executing and in the evident enthusiasm we've and United the States. new
on LENSAR, looking quarter they increase surgical point, This recent at this cataract XX% Market US of that entire of we for XXX received of for procedures points To only were by demonstrates LENSAR estimate for an performed all the assisted in ALLY. published represents adoption quarter systems the Scope, important growth as industry. catalyst, time the the not femtosecond over laser XXXX, This clearly an clearance ALLY second first XXXX. FDA of data of the basis but
and to ALLY, This of among fact, reinforces In growth quarter proposition. was are expectations practice our of level previous to over users ALLY's ahead XX% of first operational LLS, the who that volumes transitioned procedure are have value XXXX. internal level efficiencies generation, fundamental up our
reach the is and continued as premium world our in market represents largest beyond. to expand share we market Importantly, US procedure critical the ALLY's growth XXXX the in and
systems and awkward of who technologically from other transition difficult be feedback tell to I competitors. users customers from practice. to have can the made commercial being of and we into reception Most and ours ergonomic makes today are in as ALLY with previous days adaptable field less our are are less slower, early their its countless capable, both mentioned, pleased the integrate There just availability. much the our technology brings, to the and the more the are nearly from extremely positive, based those sizing addition and data of femtosecond lasers, efficient, generation particularly on the in them you As not surgeon from advantages aging continues in that
Evident to industry We backlog consistently XX to supply continues to for from expect have but high year. these abate demand a impacted issues by ALLY's to throughout been affected grow since remain systems, and that chain of the continue whole, the the launch. as the we challenges continue
and front, we've at On of Cataract major San This meeting team Diego. we Surgery has month, active to presence and advanced ALLY's worked and dedicated skilled the the maintained Ophthalmic the American our Refractive marketing Congresses. diligently showcase in Society an attended Annual capabilities,
ALLY's In a posters non-LENSAR as contracts meeting prime the addition number outcomes, two enthusiasm, with signed this example contracts a customers, for of requests in representing record completed more XX we resulted to with ALLY and superior Again, new of customers. highlighting the systems. XX we improved and additional productivity received demos than
on first working agreements multi-system which multi-system is Additionally, and this launch several I'm surprise. pleasant stage announce our our that are secured at facilities with we excited of additional a early contracts, to have
technology effectiveness market that to industry's the performance. to The us and have systems level been solutions. placed to secure able recognition of in and also of the begin months that to following a these multi-system our our fact the testament and benefits to platform propelling It the We trust offer, XX in confidence schedule materializing the ahead leader advantages of a we company, of forefront demand XX unique anticipated and highlights is agreements initially our the this of product launch.
Looking Overall the in were our more compared volumes of for XX% meets performance at procedure to quarter XXXX. the eye. volumes first quarter, much there's down business than what procedure the
driven Korean essentially surgical payors ophthalmic eliminated time the and was purchases South being. challenges However, practices between market third-party have the by this where decrease for procedure
will We not expect have timeframe. that this for this do clear foreseeable and challenge a future resolution continue
region million in procedures $X.X revenue the The for of and first XXXX. approximately X,XXX accounted of quarter
the of quarter X% would've for to first first the to South increased revenue Excluding XXXX the compared quarter attributable XXXX. quarter XXXX revenue Korea, first
strategic to which proceeds closing proceeds, placement, gross to breakeven. private our will cash flow the empower runway we in sales of provides us a grow. further will capitalizing and penetration and Today believe resources ensuring in are demand effectively distribution million has ALLY, our been the we significantly $XX These to announced with operations make we which and that marketing which our investments and market to on and cash and extends fund production also of maximizing inventory continues shown enhance
highlights call turn for me over to our Now quarter. let the cover financial Tom Tom? to the